George Yancopoulos, President and Chief Scientific at REGENERON PHARMACEUTICALS, INC. (REGN), sold 356,779 shares at $474.52 ($168.6M) on 2020-03-10, disclosed to the SEC on 2020-03-11.
Open-market sale of $168.6M REGN by President and Chief Scientific. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $476.42 | 50,545 | $24.1M | 14.3% |
| 2 | $476.42 | 78,376 | $37.3M | 22.1% |
| 3 | $461.79 | 1,159 | $535K | 0.3% |
| 4 | $461.79 | 1,159 | $535K | 0.3% |
| 5 | $462.43 | 3,317 | $1.5M | 0.9% |
| 6 | $462.43 | 3,317 |
| $1.5M |
| 0.9% |
| 7 | $463.54 | 5,463 | $2.5M | 1.5% |
| 8 | $463.54 | 5,463 | $2.5M | 1.5% |
| 9 | $464.59 | 5,099 | $2.4M | 1.4% |
| 10 | $464.59 | 5,099 | $2.4M | 1.4% |
| 11 | $465.45 | 7,068 | $3.3M | 2.0% |
| 12 | $465.45 | 7,068 | $3.3M | 2.0% |
| 13 | $466.58 | 11,916 | $5.6M | 3.3% |
| 14 | $466.58 | 11,916 | $5.6M | 3.3% |
| 15 | $467.53 | 10,023 | $4.7M | 2.8% |
| 16 | $467.53 | 10,023 | $4.7M | 2.8% |
| 17 | $468.49 | 8,542 | $4.0M | 2.4% |
| 18 | $468.49 | 8,542 | $4.0M | 2.4% |
| 19 | $469.46 | 7,250 | $3.4M | 2.0% |
| 20 | $470.48 | 5,531 | $2.6M | 1.5% |
| 21 | $470.48 | 5,531 | $2.6M | 1.5% |
| 22 | $471.34 | 5,258 | $2.5M | 1.5% |
| 23 | $471.34 | 5,258 | $2.5M | 1.5% |
| 24 | $472.56 | 10,270 | $4.9M | 2.9% |
| 25 | $472.56 | 10,270 | $4.9M | 2.9% |
| 26 | $473.39 | 8,024 | $3.8M | 2.3% |
| 27 | $473.39 | 8,024 | $3.8M | 2.3% |
| 28 | $474.52 | 7,060 | $3.4M | 2.0% |
| 29 | $474.52 | 7,060 | $3.4M | 2.0% |
| 30 | $475.43 | 4,223 | $2.0M | 1.2% |
| 31 | $475.43 | 4,223 | $2.0M | 1.2% |
| 32 | $476.51 | 7,197 | $3.4M | 2.0% |
| 33 | $476.51 | 7,197 | $3.4M | 2.0% |
| 34 | $477.50 | 4,735 | $2.3M | 1.3% |
| 35 | $477.50 | 4,735 | $2.3M | 1.3% |
| 36 | $478.43 | 1,469 | $703K | 0.4% |
| 37 | $478.43 | 1,469 | $703K | 0.4% |
| 38 | $479.60 | 1,651 | $792K | 0.5% |
| 39 | $479.60 | 1,651 | $792K | 0.5% |
| 40 | $480.34 | 60 | $29K | 0.0% |
| 41 | $481.68 | 100 | $48K | 0.0% |
| 42 | $483.80 | 355 | $172K | 0.1% |
| 43 | $484.72 | 345 | $167K | 0.1% |
| 44 | $484.72 | 345 | $167K | 0.1% |
| 45 | $485.63 | 1,693 | $822K | 0.5% |
| 46 | $485.63 | 1,693 | $822K | 0.5% |
| 47 | $486.31 | 7 | $3K | 0.0% |
| Total | $472.62 avg | 356,779 | $168.6M | 100% |
| Filing → |
| REGN | SELL | 2024-01-04 | $15.2M | — | Filing → |
| REGN | SELL | 2023-03-27 | $5.0M | — | Filing → |
| REGN | SELL | 2023-02-08 | $21.1M | — | Filing → |